Biblio

Export 2957 results:
Author Title Type [ Year(Asc)]
2023
J. Lilek, Ajroud, K., Feldman, A. Z., Krishnamachari, S., Ghourchian, S., Gefen, T., Spencer, C. L., Kawles, A., Mao, Q., Tranovich, J. F., Jack, C. R., Mesulam, M. - M., R Reichard, R., Zhang, H., Murray, M. E., Knopman, D., Dickson, D. W., Petersen, R. C., Smith, B., Ashe, K. H., Mielke, M. M., Nelson, K. M., and Flanagan, M. E., Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer's Disease., J Alzheimers Dis, vol. 92, no. 1, pp. 241-260, 2023.
H. Salem, Suchting, R., Gonzales, M. M., Seshadri, S., and Teixeira, A. L., Apathy as a Predictor of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Texas Alzheimer's Research and Care Consortium (TARCC) Cohort-Based Analysis., J Alzheimers Dis, vol. 92, no. 1, pp. 129-139, 2023.
P. Ding, Gorenflo, M. P., Zhu, X., and Xu, R., Aspirin Use and Risk of Alzheimer's Disease: A 2-Sample Mendelian Randomization Study., J Alzheimers Dis, 2023.
E. van den Berg, Nilsson, J., Kersten, I., Brinkmalm, G., de Kort, A. M., Klijn, C. J. M., Schreuder, F. H. B. M., Jäkel, L., Gobom, J., Portelius, E., Zetterberg, H., Brinkmalm, A., Blennow, K., H Kuiperij, B., and Verbeek, M. M., Cerebrospinal Fluid Panel of Synaptic Proteins in Cerebral Amyloid Angiopathy and Alzheimer's Disease., J Alzheimers Dis, 2023.
C. W. Zhu, Gu, Y., Kociolek, A. J., Fernandez, K. K., Cosentino, S., and Stern, Y., Costs During the Last Five Years of Life for Patients with Clinical and Pathological Confirmed Diagnosis of Lewy Body Dementia and Alzheimer's Disease., J Alzheimers Dis, 2023.
C. Liu, Lee, S. H., Loewenstein, D. A., Galvin, J. E., Levin, B. E., McKinney, A., and Alperin, N., Early Amnestic Mild Cognitive Impairment Is Associated with Reduced Total Cerebral Blood Flow with no Brain Tissue Loss., J Alzheimers Dis, vol. 91, no. 4, pp. 1313-1322, 2023.
N. Acosta-Baena, Lopera-Gómez, C. M., Jaramillo-Elorza, M. C., Velilla-Jiménez, L., Villegas-Lanau, C. Andrés, Sepúlveda-Falla, D., Arcos-Burgos, M., and Lopera, F., Early Depressive Symptoms Predict Faster Dementia Progression in Autosomal-Dominant Alzheimer's Disease., J Alzheimers Dis, 2023.
S. Bouges, Fischer, B., Norton, D. L., Wyman, M. F., Lambrou, N., Zuelsdorff, M., Van Hulle, C. A., Ennis, G. E., James, T. T., Johnson, A. L., Chin, N., Carlsson, C. M., and Gleason, C. E., Effect of Metabolic Syndrome Risk Factors on Processing Speed and Executive Function in Three Racialized Groups., J Alzheimers Dis, vol. 92, no. 1, pp. 285-294, 2023.
J. María García-Alberca, Gris, E., de la Guía, P., Mendoza, S., and de la Rica, M. López, Efficacy of Souvenaid® Combined with Acetylcholinesterase Inhibitors in the Treatment of Mild Alzheimer's Disease., J Alzheimers Dis, vol. 91, no. 4, pp. 1459-1469, 2023.
J. Wang, Yu, N. - W., Wang, D. - Z., Guo, L., Yang, S., Zheng, B., Guo, F. - Q., and Wang, J. - H., Helicobacter pylori Infection Is Associated with Long-Term Cognitive Decline in Older Adults: A Two-Year Follow-Up Study., J Alzheimers Dis, vol. 91, no. 4, pp. 1351-1358, 2023.
A. Abraham Daniel, Silzer, T., Sun, J., Zhou, Z., Hall, C., Phillips, N., and Barber, R., Hypermethylation at CREBBP Is Associated with Cognitive Impairment in a Mexican American Cohort., J Alzheimers Dis, 2023.
S. Toppala, Ekblad, L. L., Viitanen, M., Rinne, J. O., and Jula, A., Impaired Early Insulin Response to Glucose Load Predicts Episodic Memory Decline: A 10-Year Population-Based Cohort Follow-Up of 45-74-Year-Old Men and Women., J Alzheimers Dis, vol. 92, no. 1, pp. 349-359, 2023.
R. Tandon, Levey, A. I., Lah, J. J., Seyfried, N. T., and Mitchell, C. S., Machine Learning Selection of Most Predictive Brain Proteins Suggests Role of Sugar Metabolism in Alzheimer's Disease., J Alzheimers Dis, 2023.
R. R. Corrigan, Labrador, L., Grizzanti, J., Mey, M., Piontkivska, H., and Casadesus-Smith, G., Neuroprotective Mechanisms of Amylin Receptor Activation, Not Antagonism, in the APP/PS1 Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 91, no. 4, pp. 1495-1514, 2023.
H. Kikuchi, Takahashi, M., Komatsu, H., and Axelsen, P. H., Post-Translational Chemical Modifications of Amyloid-β Peptides by 4-Hydroxy-2-Nonenal., J Alzheimers Dis, 2023.
T. Voss, Kost, J., Mercer, S. Pal, Furtek, C., Randolph, C., Lines, C., Egan, M. F., and Cummings, J. L., Progression from Prodromal Alzheimer's Disease to Mild Alzheimer's Disease Dementia in the Verubecestat APECS Study: Adjudicating Diagnostic Transitions., J Alzheimers Dis, vol. 92, no. 1, pp. 341-348, 2023.
S. Chen, Cardinal, R. N., Gräf, S., O'Brien, J. T., and Underwood, B. R., Risk Factors for Longer-Term Mortality in Discharged Patients with Dementia and SARS-CoV-2 Infection: A Matched Case-Control Study., J Alzheimers Dis, vol. 92, no. 1, pp. 295-309, 2023.
E. Z. Huie, Escudero, A., Saito, N., Harvey, D., Le Nguyen, M. -, Lucot, K. L., LaGrande, J., Mungas, D., DeCarli, C., Lamar, M., Schneider, J. A., Kapasi, A., Rissman, R. A., Teich, A. F., and Dugger, B. N., TDP-43 Pathology in the Setting of Intermediate and High Alzheimer's Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial Groups., J Alzheimers Dis, vol. 91, no. 4, pp. 1291-1301, 2023.
M. Yoshida, Uemura, T., Mizoi, M., Waragai, M., Sakamoto, A., Terui, Y., Kashiwagi, K., and Igarashi, K., Urinary Amino Acid-Conjugated Acrolein and Taurine as New Biomarkers for Detection of Dementia., J Alzheimers Dis, vol. 92, no. 1, pp. 361-369, 2023.
2022
X. - Y. He, Dobkin, C., W Brown, T., and Yang, S. - Y., 3-Hydroxyacyl-CoA and Alcohol Dehydrogenase Activities of Mitochondrial Type 10 17β-Hydroxysteroid Dehydrogenase in Neurodegeneration Study., J Alzheimers Dis, vol. 88, no. 4, pp. 1487-1497, 2022.
L. Chen, Shen, Q., Xu, S., Yu, H., Pei, S., Zhang, Y., He, X., Wang, Q. Z., and Li, D., 5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 2, pp. 573-585, 2022.
C. G. Pontrello, McWhirt, J. M., Glabe, C. G., and Brewer, G. J., Age-Related Oxidative Redox and Metabolic Changes Precede Intraneuronal Amyloid-β Accumulation and Plaque Deposition in a Transgenic Alzheimer's Disease Mouse Model., J Alzheimers Dis, vol. 90, no. 4, pp. 1501-1521, 2022.
E. M. Khedr, Omeran, N., Ramadan, H. Karam- Alla, Ahmed, G. K., and Abdelwarith, A. M., Alteration of Gut Microbiota in Alzheimer's Disease and Their Relation to the Cognitive Impairment., J Alzheimers Dis, vol. 88, no. 3, pp. 1103-1114, 2022.
A. Xu, Kouznetsova, V. L., and Tsigelny, I. F., Alzheimer's Disease Diagnostics Using miRNA Biomarkers and Machine Learning., J Alzheimers Dis, vol. 86, no. 2, pp. 841-859, 2022.
K. C Kim, Lee, Y. Rui, Ong, L., Gold, M., Kalali, A., and Sarkar, J., Alzheimer's Disease: Key Insights from Two Decades of Clinical Trial Failures., J Alzheimers Dis, vol. 87, no. 1, pp. 83-100, 2022.

Pages